Adam Hawkins, Director International Markets

An estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred Worldwide in 2020 (GLOBOCAN 2020). In Australia, cancer is the leading cause of health burden. More than 1 million people in…

Rare disease Day, recognises the 6,000+ identified, often life threatening, rare diseases*. Impacting over 300 million people worldwide, 72% of rare diseases are genetic, with 70% of those starting in childhood*. The low prevalence and…

Quarterly Recognition Awards At Prospection we believe that our values drive our behaviours and they’re what make all of us stand out from the crowd. This week we celebrated the incredible contributions from our whole…

Prospection integrate and analyse a range of data that includes administrative claims data, electronic medical records, hospital and insurance data and other big data sets. The integration and analysis of this data provides real world…

Machine learning and artificial intelligence tools (ML/AI) rapidly detect patterns the human eye can’t easily see. Analyse large patient datasets to understand and predict patterns to improve health outcomes. Pharma data insights using real world…

Recognition Awards Winners At Prospection we believe that our values drive our behaviours and they’re what make all of us at Prospection stand out from the crowd. Congratulations to all of our winners and thank…

Advances in medical innovation are leading toward precision medicine, matching disease to targeted treatment. Data modelling using advanced technology has become important to support this development. Prospection Labs is where experimental and innovative ideas come…

PharmDash is a real-world evidence platform that delivers insights into the use, value, and outcomes of different medications across all disease areas.  Initially designed to work with the Australian Pharmaceutical Benefits Scheme (PBS) longitudinal patient…

Today, we announce the opening of our Japan headquarters. With the appointment of health informatics and pharmaceutical veteran Kaoru Sato to lead our Japan operations. The new office in Tokyo will enable Prospection to work closely with international pharmaceutical and research partners. Offering the full suite of our health data science capabilities.

PharmMap provides geospatial data insights through integration of multiple health datasets. Purpose built to assist life science companies, PharmMap is a prominent tool within the Prospection product portfolio. It integrates operational and longitudinal health data…

Prospection has developed into a company that clients can trust to help them achieve success. Our advanced knowledge and expertise in healthcare data analytics supports complex research questions. The experience and expertise of the 3 founders Eric, Ricky and Peter have contributed highly towards the rapid growth and success of Prospection

Prospection is a health data analytics company that is currently based in Sydney. In the beginning Prospection started with just 3 people, its founders Eric, Ricky and Peter. 8 years on Prospection has thrived, growing…

The global COVID-19 pandemic brings into sharp focus how timely access to linked datasets supports more efficient decision making. Australia was lauded for its management of the global health challenge with so few lives lost….